scorecardresearchEris Lifesciences Share Price Live NSE, BSE, Today - Eris Lifesciences
Mintgenie
Asian Paints2,924.6047.55 (1.65%)
Axis Bank1,164.85-1.30 (-0.11%)
Bajaj Finance6,917.85-13.20 (-0.19%)
Bajaj Finserv1,621.906.20 (0.38%)
Bharti Airtel1,306.85-16.00 (-1.21%)
HCL Technologies1,368.751.20 (0.09%)
HDFC Bank1,534.7517.70 (1.17%)
Hindustan Unilever2,242.2511.55 (0.52%)
ICICI Bank1,142.10-9.95 (-0.86%)
ITC437.752.15 (0.49%)
Indusind Bank1,509.35-6.25 (-0.41%)
Infosys1,419.65-1.45 (-0.10%)
Kotak Mahindra Bank1,562.70-61.05 (-3.76%)
Larsen & Toubro3,605.0010.85 (0.30%)
Mahindra & Mahindra2,181.2524.95 (1.16%)
Maruti Suzuki India12,714.00-92.45 (-0.72%)
NTPC367.254.15 (1.14%)
Nestle India2,537.5031.45 (1.25%)
Power Grid Corporation Of India315.9014.25 (4.72%)
Reliance Industries2,949.3018.15 (0.62%)
State Bank Of India832.056.35 (0.77%)
Sun Pharmaceutical Industries1,522.2519.95 (1.33%)
Tata Consultancy Services3,851.9029.30 (0.77%)
Tata Motors1,024.2016.35 (1.62%)
Tata Steel167.252.30 (1.39%)
Tech Mahindra1,265.203.25 (0.26%)
Titan Company3,572.60-16.55 (-0.46%)
Ultratech Cement9,977.3510.60 (0.11%)
Wipro458.30-4.00 (-0.87%)

Eris Lifesciences

BSE: 540596 | NSE: ERIS | ISIN: INE406M01024 | SECTOR: Biotechnology & Drugs

₹892.50 0.90 (0.1%)

02 May 2024, 05:08 (IST)

  • Open

    898.95

  • High

    898.95

  • Low

    881.70

  • Prev Close

    891.60

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    121.42B

  • Volume

    3.58K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    892.00

  • Ask

    892.50
View all metrics

Promoter Pledge Holding - 10.16%

Promoter NameNo of SharesPercentage
Amit Indubhushan Bakshi81,76,4706.01%
Inderjeet Singh Negi18,82,5001.38%
Rajendrakumar Rambhai Patel18,82,5001.38%
Kaushal Kamleshkumar Shah18,82,5001.38%

Company Description

  • Biotechnology & Drugs

  • BSE

    540596

  • NSE

    ERIS

  • ISIN

    INE406M01024

Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.

Company Officers

  • Amit Bakshi

    Chairman of the Board, Managing Director, Executive Director

  • Sachin Shah

    Chief Financial Officer

  • Krishnakumar Vaidyanathan

    Chief Operating Officer, Executive Director

  • Milind Talegaonkar

    Compliance Officer, Company Secretary

  • Inderjeet Negi

    Executive Director

  • Kaushal Shah

    Executive Director